Anti-VEGF treatment switch in real-world DME patients: ranibizumab versus aflibercept for bevacizumab DME non-responding patients (SWIRL study) by Yu Qiang Soh, Zheng Xian Thng, Wei Kiong Ngo, Colin S Tan, Tock Han Lim, Louis W Lim, Augustinus Laude, Darren Choy, Wen Jun Song, Helen Fang Mi, Koh Lilian, Jacob Yu Hang Chin, Karen Jhi Wen Chia, Issac Too, Nicola Y Gan, Rajesh Rajagopalan

Get full text

Onset of End-Stage Atrophic Age-Related Macular Degeneration as an End Point—A Delphi Study: Classification of Atrophy Meetings Report 7 by Zhichao Wu, BAppSc(Optom), PhD, Srinivas R. Sadda, MD, Thomas Ach, MD, Barbara A. Blodi, MD, Ferdinando Bottoni, MD, Usha Chakravarthy, MD, PhD, Emily Y. Chew, MD, Christine A. Curcio, PhD, Frederick L. Ferris, III, MD, Monika Fleckenstein, MD, K. Bailey Freund, MD, Juan E. Grunwald, MD, Frank G. Holz, MD, Glenn J. Jaffe, MD, Sandra Liakopoulos, MD, Tock Han Lim, FRCSEd, Jordi M. Monés, MD, PhD, Sergio Pagliarini, MD, FRCOphth, Daniel Pauleikhoff, MD, Maximilian Pfau, MD, Philip J. Rosenfeld, MD, PhD, David Sarraf, MD, Steffen Schmitz-Valckenberg, MD, Richard F. Spaide, MD, Janet R. Sparrow, PhD, Giovanni Staurenghi, MD, Adnan Tufail, MD, Francesco Viola, MD, Robyn H. Guymer, MBBS, PhD

Get full text